Search results for: 'vaccine 2016 2016 deal trend players and financi'
- Did you mean
- vaccine 221b 221b deaf trans plagens and financi
- Related search terms
- vaccine 2024 2020 deal trend players and financi
- vaccine 2024 2020 deal trends players and financi
- vaccine deal and alliance of 2025
- vaccine 2020 2025 deal trends players and financial
- vaccine 2004 221b deal trend plagens and financial
-
Gene Editing Collaboration and Licensing Deals 2016-2025May 2025$3,995.00Gene Editing Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Cancer Monoclonal Antibody Collaboration and Licensing Deals 2016-2025May 2025$3,995.00Cancer Monoclonal Antibody Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Syndromic Multiplex Diagnostics: Strategies and Trends, Market Forecasts by Syndrome, Place, Product and Country with Analysis and Executive Guides 2025-2029January 2025$6,995.00Syndromic Multiplex Diagnostics Markets | Global coverage | Market size | Actionable insights| Trends | Key companies | Growth forecasts
Learn More -
Precision Medicine in Oncology Collaboration and Licensing Deals 2016-2025July 2025$3,995.00Precision Medicine in Oncology Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Clinical Stage Partnering Terms and Agreements in Pharmaceuticals and Biotechnology 2020-2025August 2025$4,995.00The Clinical Stage Partnering Terms and Agreements in Pharma and Biotech (2020-2025) report offers in-depth insights and exclusive access to clinical-stage partnering agreements signed by the world’s leading biopharma companies, providing a detailed analysis of deal structures, financial terms and strategic collaborations.
Learn More -
Regenerative Medicine Collaboration and Licensing Deals 2019-2025May 2025$3,995.00Regenerative Medicine Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2019 to 2025
Learn More -
Infectious Diseases Collaboration and Licensing Deals 2019-2025April 2025$3,995.00Infectious Diseases Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals | Comprehensive deal directory 2019 to 2025
Learn More -
Merger and Acquisition (M&A) Deals in Pharmaceuticals, Biotechnology and Diagnostics 2020-2025February 2025$3,995.00Global coverage | Deal financials | Contract documents | Deal trends | Leading M&A dealmakers | Comprehensive deal directory 2020 to 2025
Learn More -
CP Knowledge CenterAugust 2025$14,995.00The All In One Partnering Intelligence Platform
Get unlimited access to our partnering report library conveniently and easily, while maximizing your time and budget
Learn More -
Monoclonal Antibody Collaboration and Licensing Deals 2019-2025May 2025$3,995.00Monoclonal Antibody Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More
